PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33243092-0	2020	Effect of CYP3A5*3 genotypes on lumefantrine plasma concentrations among malaria-HIV-infected women.	Lumefantrine	32-44	cytochrome P450 family 3 subfamily A member 5	Homo sapiens	10-16	
33243092-1	2020	Aim: We aimed to assess the effect of a functional polymorphism of CYP3A5 on lumefantrine pharmacokinetics.	Lumefantrine	77-89	cytochrome P450 family 3 subfamily A member 5	Homo sapiens	67-73	
33243092-8	2020	Conclusion: CYP3A5*3 genetic variant is associated with a high maximum plasma concentration of lumefantrine.	Lumefantrine	95-107	cytochrome P450 family 3 subfamily A member 5	Homo sapiens	12-18	
31744845-0	2019	Pregnancy and CYP3A5 Genotype Affect Day 7 Plasma Lumefantrine Concentrations.	Lumefantrine	50-62	cytochrome P450 family 3 subfamily A member 5	Homo sapiens	14-20	
31744845-13	2019	SIGNIFICANCE STATEMENT: This study reports a number of factors contributing to the lower day 7 lumefantrine (LF) concentration in women, which includes pregnancy, body weight, and CYP3A5*1/*1 genotype.	Lumefantrine	95-107	cytochrome P450 family 3 subfamily A member 5	Homo sapiens	180-186